Home>News & Events>Publications>RDCA-DAP

News & Events

  • January 8, 2021

    Effective Data Sharing as a Conduit for Advancing Medical Product Development

     Patient-level data sharing has the potential to significantly impact the lives of patients by optimizing and improving the medical product development process. In the product development setting, successful data sharing is defined as data sharing that is actionable and facilitates decision making during the development and review of medical products. This often occurs through the......
Refine:

Period

Program

  • All Programs
  • CPAD - Critical Path for Alzheimer's Disease
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • PredicTox KE - PredicTox Knowledge Environment
  • CP-SCD - Critical Path for Sickle Cell Disease
  • CDRC - CURE Drug Repurposing Collaboratory
  • QuantMed - Quantitative Medicine Program
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • T1D - Type 1 Diabetes Consortium
  • TTC - Transplant Therapeutics Consortium
  • CFAST - Coalition For Accelerating Standards and Therapies
  • BmDR - Biomarker Data Repository
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • ePRO Consortium - Electronic Patient-Reported Outcome Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x